TABLE OF CONTENTS
| | | | Volume 114, Issue 2 (125-236) Published online 19 January 2016 | | In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics & Genomics
Also new today Advance online publication Digital Edition | | | | Minireview | Top | | Gene–environment interaction and risk of breast cancerAnja Rudolph, Jenny Chang-Claude and Marjanka K Schmidt Br J Cancer 2016 114: 125-133; advance online publication, January 12, 2016; 10.1038/bjc.2015.439 Abstract | Full Text | | Clinical Studies | Top | | Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancerDuncan C Gilbert, Eva Serup-Hansen, Dorte Linnemann, Estrid Høgdall, Charles Bailey, Jeff Summers, Hanne Havsteen and Gareth J Thomas Br J Cancer 2016 114: 134-137; advance online publication, January 5, 2016; 10.1038/bjc.2015.448 Abstract | Full Text | | | | Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancerYilin Li, Jifang Gong, Qiyue Zhang, Zhihao Lu, Jing Gao, Yanyan Li, Yanshuo Cao and Lin Shen Br J Cancer 2016 114: 138-145; 10.1038/bjc.2015.417 Abstract | Full Text | | | | Has the survival of patients with glioblastoma changed over the years?R M deSouza, H Shaweis, C Han, V Sivasubramiam, L Brazil, R Beaney, G Sadler, S Al-Sarraj, T Hampton, J Logan, V Hurwitz, R Bhangoo, R Gullan and K Ashkan Br J Cancer 2016 114: 146-150; advance online publication, December 15, 2015; 10.1038/bjc.2015.421 Abstract | Full Text | | | | A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumoursMatthew J Murray, Emma Bell, Katie L Raby, Martin A Rijlaarsdam, Ad J M Gillis, Leendert H J Looijenga, Helen Brown, Benoit Destenaves, James C Nicholson and Nicholas Coleman Br J Cancer 2016 114: 151-162; advance online publication, December 15, 2015; 10.1038/bjc.2015.429 Abstract | Full Text | | | | Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancerChristoph Zielinski, Istvan Lang, Semir Beslija, Zsuzsanna Kahan, Moshe J Inbar, Salomon M Stemmer, Rodica Anghel, Damir Vrbanec, Diethelm Messinger and Thomas Brodowicz Br J Cancer 2016 114: 163-170; advance online publication, December 10, 2015; 10.1038/bjc.2015.419 Abstract | Full Text | | | | A randomised trial of the effect of postal reminders on attendance for breast screeningPrue C Allgood, Anthony J Maxwell, Sue Hudson, Judith Offman, Gillian Hutchison, Cathryn Beattie, Raquel Tuano-Donnelly, Anthony Threlfall, Tina Summersgill, Lesley Bellis, Collette Robinson, Samantha Heaton, Julietta Patnick and Stephen W Duffy Br J Cancer 2016 114: 171-176; 10.1038/bjc.2015.451 Abstract | Full Text | | Translational Therapeutics | Top | | Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancerMarie-Emmanuelle Legrier, Ivan Bièche, Julie Gaston, Arnaud Beurdeley, Vanessa Yvonnet, Olivier Déas, Aurélie Thuleau, Sophie Château-Joubert, Jean-Luc Servely, Sophie Vacher, Myriam Lassalle, Stéphane Depil, Gordon C Tucker, Jean-Jacques Fontaine, Marie-France Poupon, Sergio Roman-Roman, Jean-Gabriel Judde, Didier Decaudin, Stefano Cairo and Elisabetta Marangoni Br J Cancer 2016 114: 177-187; advance online publication, December 22, 2015; 10.1038/bjc.2015.398 Abstract | Full Text | | | | Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapantZ Zakaria, A Tivnan, L Flanagan, D W Murray, M Salvucci, B W Stringer, B W Day, A W Boyd, D Kögel, M Rehm, D F O’Brien, A T Byrne and J H M Prehn Br J Cancer 2016 114: 188-198; advance online publication, December 10, 2015; 10.1038/bjc.2015.420 Abstract | Full Text | | | | Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasisSun A Kim, Kentaro Inamura, Mai Yamauchi, Reiko Nishihara, Kosuke Mima, Yasutaka Sukawa, Tingting Li, Mika Yasunari, Teppei Morikawa, Kathryn C Fitzgerald, Charles S Fuchs, Kana Wu, Andrew T Chan, Xuehong Zhang, Shuji Ogino and Zhi Rong Qian Br J Cancer 2016 114: 199-206; advance online publication, January 7, 2016; 10.1038/bjc.2015.347 Abstract | Full Text | | Molecular Diagnostics | Top | | Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomyBimal Bhindi, Thomas Hermanns, Yanliang Wei, Julie Yu, Patrick O Richard, Marian S Wettstein, Arnoud Templeton, Kathy Li, Srikala S Sridhar, Michael A S Jewett, Neil E Fleshner, Alexandre R Zlotta and Girish S Kulkarni Br J Cancer 2016 114: 207-212; advance online publication, December 10, 2015; 10.1038/bjc.2015.432 Abstract | Full Text | | | | E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancerFabian Trillsch, Sascha Kuerti, Christine Eulenburg, Eike Burandt, Linn Woelber, Katharina Prieske, Kathrin Eylmann, Leticia Oliveira-Ferrer, Karin Milde-Langosch and Sven Mahner Br J Cancer 2016 114: 207-212; 10.1038/bjc.2015.436 Abstract | Full Text | | Genetics & Genomics | Top | | CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer riskXabier Garcia-Albeniz, Anja Rudolph, Carolyn Hutter, Emily White, Yi Lin, Stephanie A Rosse, Jane C Figueiredo, Tabitha A Harrison, Shuo Jiao, Hermann Brenner, Graham Casey, Thomas J Hudson, Mark Thornquist, Loic Le Marchand, John Potter, Martha L Slattery, Brent Zanke, John A Baron, Bette J Caan, Stephen J Chanock, Sonja I Berndt, Deanna Stelling, Charles S Fuchs, Michael Hoffmeister, Katja Butterbach, Mengmeng Du, W James Gauderman, Marc J Gunter, Mathieu Lemire, Shuji Ogino, Jennifer Lin, Richard B Hayes, Robert W Haile, Robert E Schoen, Greg S Warnick, Mark A Jenkins, Stephen N Thibodeau, Fredrick R Schumacher, Noralane M Lindor, Laurence N Kolonel, John L Hopper, Jian Gong, Daniela Seminara, Bethann M Pflugeisen, Cornelia M Ulrich, Conghui Qu, David Duggan, Michelle Cotterchio, Peter T Campbell, Christopher S Carlson, Polly A Newcomb, Edward Giovannucci, Li Hsu, Andrew T Chan, Ulrike Peters and Jenny Chang-Claude Br J Cancer 2016 114: 221-229; advance online publication, January 14, 2016; 10.1038/bjc.2015.443 Abstract | Full Text | | | | Hypermethylation of genes in testicular embryonal carcinomasHoi-Hung Cheung, Yanzhou Yang, Tin-Lap Lee, Owen Rennert and Wai-Yee Chan Br J Cancer 2016 114: 230-236; advance online publication, December 1, 2015; 10.1038/bjc.2015.408 Abstract | Full Text | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. | | | | |
No comments:
Post a Comment